415 related articles for article (PubMed ID: 18388685)
21. Sorbent-based artificial liver devices: principles of operation, chemical effects and clinical results.
Carpentier B; Ash SR
Expert Rev Med Devices; 2007 Nov; 4(6):839-61. PubMed ID: 18035950
[TBL] [Abstract][Full Text] [Related]
22. ["Artificial liver"].
Azzena G
Ann Ital Chir; 2000; 71(3):281-3. PubMed ID: 11014006
[TBL] [Abstract][Full Text] [Related]
23. Orthotopic liver transplantation for fulminant hepatic failure.
Nyckowski P; Skwarek A; Zieniewicz K; Patkowski W; Alsharabi A; Wróblewski T; Remiszewski P; Smoter P; Kotulski M; Korba M; Paczkowska A; Giercuszkiewicz D; Sańko-Resmer J; Paczek L; Krawczyk M
Transplant Proc; 2006; 38(1):219-20. PubMed ID: 16504707
[TBL] [Abstract][Full Text] [Related]
24. Bioartificial liver assist devices in support of patients with liver failure.
Patzer II JF; Lopez RC; Zhu Y; Wang ZF; Mazariegos GV; Fung JJ
Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):18-25. PubMed ID: 14607616
[TBL] [Abstract][Full Text] [Related]
25. Liver support systems.
Sorkine P; Ben Abraham R; Brill S; Szold O
Isr Med Assoc J; 2001 Jan; 3(1):44-9. PubMed ID: 11344803
[TBL] [Abstract][Full Text] [Related]
26. Extracorporeal liver support therapy with Prometheus in patients with liver failure in the intensive care unit.
Oppert M; Rademacher S; Petrasch K; Jörres A
Ther Apher Dial; 2009 Oct; 13(5):426-30. PubMed ID: 19788460
[TBL] [Abstract][Full Text] [Related]
27. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure.
Oettl K; Stadlbauer V; Krisper P; Stauber RE
Ther Apher Dial; 2009 Oct; 13(5):431-6. PubMed ID: 19788461
[TBL] [Abstract][Full Text] [Related]
28. [Non biological artificial devices: what do they mean and what is their role today?].
Rosa-Diez G; Gadano A
Acta Gastroenterol Latinoam; 2012 Jun; 42(2):135-44. PubMed ID: 22876717
[TBL] [Abstract][Full Text] [Related]
29. Bench-to-bedside review: current evidence for extracorporeal albumin dialysis systems in liver failure.
Karvellas CJ; Gibney N; Kutsogiannis D; Wendon J; Bain VG
Crit Care; 2007; 11(3):215. PubMed ID: 17567927
[TBL] [Abstract][Full Text] [Related]
30. Bioengineering of liver assist devices.
Tilles AW; Berthiaume F; Yarmush ML; Tompkins RG; Toner M
J Hepatobiliary Pancreat Surg; 2002; 9(6):686-96. PubMed ID: 12658402
[TBL] [Abstract][Full Text] [Related]
31. Technology insight: liver support systems.
Millis JM; Losanoff JE
Nat Clin Pract Gastroenterol Hepatol; 2005 Sep; 2(9):398-405; quiz 434. PubMed ID: 16265430
[TBL] [Abstract][Full Text] [Related]
32. [Liver and artificial liver].
Chamuleau RA
Ned Tijdschr Geneeskd; 1998 Jun; 142(23):1300-5. PubMed ID: 9752034
[TBL] [Abstract][Full Text] [Related]
33. Long-term therapy of acute chronic liver failure to successful transplantation with an extracorporeal liver support system.
Jung O; Asbe-Vollkopf A; Betz C; Caspary W; Geiger H; Faust D
Z Gastroenterol; 2007 Jan; 45(1):21-4. PubMed ID: 17236117
[TBL] [Abstract][Full Text] [Related]
34. Hepatic assist devices.
Demetriou AA
Panminerva Med; 2005 Mar; 47(1):31-7. PubMed ID: 15985975
[TBL] [Abstract][Full Text] [Related]
35. Artificial extracorporeal liver support therapy in patients with severe liver failure.
Rademacher S; Oppert M; Jörres A
Expert Rev Gastroenterol Hepatol; 2011 Oct; 5(5):591-9. PubMed ID: 21910577
[TBL] [Abstract][Full Text] [Related]
36. What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation.
Sgroi A; Serre-Beinier V; Morel P; Bühler L
Transplantation; 2009 Feb; 87(4):457-66. PubMed ID: 19307780
[TBL] [Abstract][Full Text] [Related]
37. Hepatic tissue engineering for adjunct and temporary liver support: critical technologies.
Chan C; Berthiaume F; Nath BD; Tilles AW; Toner M; Yarmush ML
Liver Transpl; 2004 Nov; 10(11):1331-42. PubMed ID: 15497161
[TBL] [Abstract][Full Text] [Related]
38. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
[TBL] [Abstract][Full Text] [Related]
39. Bioartificial liver systems: current status and future perspective.
Park JK; Lee DH
J Biosci Bioeng; 2005 Apr; 99(4):311-9. PubMed ID: 16233796
[TBL] [Abstract][Full Text] [Related]
40. [Preliminary evaluation on the effects of a hybrid bioartificial liver support system in the treatment of hepatic failure].
Wang YJ; He NH; Niu RZ; Liu J; Wen HW; Li JJ; Wang YM
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):461-3. PubMed ID: 12939175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
